Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12611001229965
Ethics application status
Approved
Date submitted
29/11/2011
Date registered
30/11/2011
Date last updated
30/11/2011
Type of registration
Retrospectively registered
Titles & IDs
Public title
Penehyclidine Hydrochloride reduces the incidence of intraoperative awareness
Query!
Scientific title
Penehyclidine Hydrochloride reduces the incidence of intraoperative awareness in patients undergoing breast cancer surgery during general anesthesia
Query!
Secondary ID [1]
273489
0
Nil
Query!
Universal Trial Number (UTN)
U1111-1126-1353
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
breast cancer
279277
0
Query!
awareness during surgery
279291
0
Query!
Condition category
Condition code
Anaesthesiology
279475
279475
0
0
Query!
Anaesthetics
Query!
Cancer
279487
279487
0
0
Query!
Breast
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Patients receive 0.01 mg.kg-1 Penehyclidine Hydrochloride intravenously 30min before surgery
Query!
Intervention code [1]
283804
0
Treatment: Drugs
Query!
Comparator / control treatment
Patients receive 0.01 mg.kg-1 saline intravenously 30min before surgery
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
286043
0
Penehyclidine Hydrochloride reduces the incidence of intraoperative awareness in patients undergoing breast cancer surgery during general anesthesia.
Query!
Assessment method [1]
286043
0
Query!
Timepoint [1]
286043
0
Every Patient was interviewed twice, at anytime between 2 and 6 hours postoperatively and at any time between 24 and 48 hours postoperatively.
Query!
Secondary outcome [1]
295031
0
Patients with higher degree anxiety levels were liable to report intraoperative awareness.
Query!
Assessment method [1]
295031
0
Query!
Timepoint [1]
295031
0
Before they received Penehyclidine Hydrochloride or saline, the patients were assessed preoperative anxiety levels by using a 100-mm visual analogue scale.
Query!
Eligibility
Key inclusion criteria
American Society of Anesthesiologists physical status I–III patients, aged 15–75 years, undergoing breast cancer surgery
Query!
Minimum age
15
Years
Query!
Query!
Maximum age
75
Years
Query!
Query!
Sex
Females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
psychosis or memory impairment, history of intraoperative awareness or brain injury, history of electroencephalographic abnormality, patients habitually using benzodiazepines, opiates, alcohol, barbiturates, carbamazepine, glucocorticoids, phenytoin and rifampicin etc. and patients who are unable to provide informed consent.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation concealment was established by placing the randomization sequence in consecutively numbered, opaque envelopes.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computerised sequence generation
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
21/01/2010
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
900
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
3983
0
China
Query!
State/province [1]
3983
0
Query!
Funding & Sponsors
Funding source category [1]
284280
0
Hospital
Query!
Name [1]
284280
0
Fudan University Cancer Hospital
Query!
Address [1]
284280
0
No.270 Dong-an Road, Shanghai, P. R. China
Query!
Country [1]
284280
0
China
Query!
Primary sponsor type
Individual
Query!
Name
Zhiming Tan
Query!
Address
Department of Anesthesiology, Fudan University Cancer Hospital, No.270 Dong-an Road, Shanghai, P. R. China
Query!
Country
China
Query!
Secondary sponsor category [1]
283231
0
Individual
Query!
Name [1]
283231
0
Jing wang
Query!
Address [1]
283231
0
Department of Anesthesiology, Fudan University Cancer Hospital, No.270 Dong-an Road, Shanghai, P. R. China
Query!
Country [1]
283231
0
China
Query!
Other collaborator category [1]
260361
0
Individual
Query!
Name [1]
260361
0
Yu Ren,Minmin Zhu,Yun Zhu,Jiawei Chen,Yajun Xu
Query!
Address [1]
260361
0
Department of Anesthesiology, Fudan University Cancer Hospital, No.270 Dong-an Road, Shanghai, P. R. China
Query!
Country [1]
260361
0
China
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
286239
0
the Cancer Hospital, Fudan University Institutional Human Ethics Committee
Query!
Ethics committee address [1]
286239
0
No.270 Dong-an Road, Shanghai, P. R. China,PC 200032.
Query!
Ethics committee country [1]
286239
0
China
Query!
Date submitted for ethics approval [1]
286239
0
23/11/2009
Query!
Approval date [1]
286239
0
20/01/2010
Query!
Ethics approval number [1]
286239
0
YJ200906
Query!
Summary
Brief summary
Extensive evidence has proved that basal forebrain cholinergic system play extremely important role in explicit memory.Penehyclidine hydrochloride (PHC; (2-hydroxyl-2-cyclopentyl-2-phenyl-ethoxy) quinuclidine) is a new anticholinergic drug with both antimuscarinic and antinicotinic activity while retaining potent central and peripheral anticholinergic activity.The primary purpose of this study is to verify the effectiveness of PHC reducing the incidence of intraoperative awareness. Modified Brice interview was used to assess awareness in the study.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
33457
0
Query!
Address
33457
0
Query!
Country
33457
0
Query!
Phone
33457
0
Query!
Fax
33457
0
Query!
Email
33457
0
Query!
Contact person for public queries
Name
16704
0
YuRen
Query!
Address
16704
0
Department of Anesthesiology, Fudan University Cancer Hospital, No.270 Dong-an Road, Shanghai, P. R. China, PC 200032.
Query!
Country
16704
0
China
Query!
Phone
16704
0
86-21-64175590(for Shanghai ,China)
Query!
Fax
16704
0
Query!
Email
16704
0
[email protected]
Query!
Contact person for scientific queries
Name
7632
0
Zhiming Tan
Query!
Address
7632
0
Department of Anesthesiology, Fudan University Cancer Hospital, No.270 Dong-an Road, Shanghai, P. R. China, PC 200032.
Query!
Country
7632
0
China
Query!
Phone
7632
0
86-21-64175590(for Shanghai ,China)
Query!
Fax
7632
0
Query!
Email
7632
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF